Sageworth Trust’s Chemours CC Stock Holding History

Sageworth Trust’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-235	Closed	-$7.04K	–	146
2023 Q1	$7.04K	Hold	235	–	–	﹤0.01%	330
2022 Q4	$7K	Hold	235	–	–	﹤0.01%	222
2022 Q3	$6K	Hold	235	–	–	﹤0.01%	221
2022 Q2	$8K	Hold	235	–	–	﹤0.01%	234
2022 Q1	$7K	Hold	235	–	–	﹤0.01%	210
2021 Q4	$8K	Sell	235 -785	-77%	-$24.5K	﹤0.01%	301
2021 Q3	$30K	Hold	1,020	–	–	﹤0.01%	271
2021 Q2	$35K	Buy	+1,020	New	+$33.8K	﹤0.01%	291

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sageworth Trust's CC Position: Q2 2023 in Review

Sageworth Trust sold out of Chemours (CC) in Q2 2023, closing a stake of 235 shares — an estimated $7.04K sold.

Sageworth Trust first reported a position in CC in Q2 2021 and held it in 8 quarters. The position peaked at $35K in Q2 2021. 476 funds tracked by Wall St. Rank hold CC as of Q2 2023.

Sageworth Trust reported no remaining Chemours position as of Q2 2023 after selling out during the quarter.
Sageworth Trust sold 235 Chemours shares in Q2 2023, an estimated $7.04K.
Sageworth Trust first reported a position in Chemours in Q2 2021 and held it in 8 quarters.
Sageworth Trust's Chemours position peaked at $35K in Q2 2021.
476 funds tracked by Wall St. Rank held Chemours as of Q2 2023.

Based on Sageworth Trust's 13F filing for Q2 2023, filed 26 Jul 2023.